Novo Nordisk A/S rStock Price (rnvo/CAD)
Buy rnvo Canada
The best way to buy Novo Nordisk A/S rStock in Canada is through Ndax, a CIRO-regulated crypto exchange. Ndax offers flat 0.2% trading fees and institutional-grade security (SOC 2 Type II), ensuring your Novo Nordisk A/S rStock (rnvo) transactions are fast, low-cost, and fully compliant with Canadian regulations. Start Trading rnvo
Novo Nordisk A/S rStock
Currency
Novo Nordisk A/S rStock
RNVO
Novo Nordisk A/S rStock Price (RNVO/CAD)
$59.42
Price Change 24h
$0.00
24h Low / 24h High
$59.07 / $60.70
Market Cap
$338,940.00
Fully Diluted Market Cap
338,940
Market Rank
#4371
Bitcoin
BTC
Bitcoin Price (BTC/CAD)
$106,216.50
Price Change 24h
-$3,272.09
2.98%24h Low / 24h High
$105,206.00 / $110,682.00
Market Cap
$2,132,411,496,420.00
3.01%Fully Diluted Market Cap
2,132,414,787,710
Market Rank
#1
Ethereum
ETH
Ethereum Price (ETH/CAD)
$3,363.68
Price Change 24h
-$141.72
4.05%24h Low / 24h High
$3,327.42 / $3,628.95
Market Cap
$410,066,725,774.00
4.08%Fully Diluted Market Cap
410,066,725,774
Market Rank
#2
Tether
USDT
Tether Price (USDT/CAD)
$1.39
Price Change 24h
-$0.0004
0.03%24h Low / 24h High
$1.39 / $1.39
Market Cap
$255,146,321,346.00
0.03%Fully Diluted Market Cap
262,750,650,157
Market Rank
#3
BNB
BNB
BNB Price (BNB/CAD)
$997.20
Price Change 24h
-$10.62
1.01%24h Low / 24h High
$990.72 / $1,019.84
Market Cap
$132,698,146,148.00
1.08%Fully Diluted Market Cap
132,698,142,899
Market Rank
#4
XRP
XRP
XRP Price (XRP/CAD)
$1.93
Price Change 24h
-$0.041
2.03%24h Low / 24h High
$1.91 / $2.07
Market Cap
$121,063,614,309.00
2.16%Fully Diluted Market Cap
192,505,930,580
Market Rank
#5
Official Site
GitHub
White Paper
Official Site
GitHub
White Paper
Novo Nordisk A/S rStock market data
Trading Volume
24h
Circulating Supply
5,706.192436753
100%
Volume / Market Cap
$0.00 / 0
Market Dominance
0%
Total Supply
5,706.192436753
BID
N/A
ASK
N/A
What Is Novo Nordisk A/S rStock (RNVO)?
Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
Other Coins
Materials related to Novo Nordisk A/S rStock
Blog
News
Videos